2016
Behavioral Interventions for Anger, Irritability, and Aggression in Children and Adolescents
Sukhodolsky DG, Smith SD, McCauley SA, Ibrahim K, Piasecka JB. Behavioral Interventions for Anger, Irritability, and Aggression in Children and Adolescents. Journal Of Child And Adolescent Psychopharmacology 2016, 26: 58-64. PMID: 26745682, PMCID: PMC4808268, DOI: 10.1089/cap.2015.0120.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyParent management trainingAnger/irritabilityTransdiagnostic approachBehavioral interventionsDisruptive behaviorAggressive behaviorChild disruptive behaviorCallous-unemotional traitsDisruptive behavior disordersTreatment of irritabilityEmotion regulationAversive patternFamily interactionsBehavioral problemsAngerMental health referralsAggressionManagement trainingBehavior disorderMood disordersTreatment targetsIrritabilityChildrenPsychiatric diagnosis
2013
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
Nurmi E, Spilman S, Whelan F, Scahill L, Aman M, McDougle C, Arnold L, Handen B, Johnson C, Sukhodolsky D, Posey D, Lecavalier L, Stigler K, Ritz L, Tierney E, Vitiello B, McCracken J. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Translational Psychiatry 2013, 3: e274-e274. PMID: 23799528, PMCID: PMC3693401, DOI: 10.1038/tp.2013.26.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAlpha-Ketoglutarate-Dependent Dioxygenase FTOAmidohydrolasesAntipsychotic AgentsBody WeightChildChild Development Disorders, PervasiveChild, PreschoolFemaleGenetic Predisposition to DiseaseHumansLeptinMaleProteinsReceptor, Cannabinoid, CB1Receptor, Melanocortin, Type 4RisperidoneWeight GainConceptsWeight gainAntipsychotic-associated weight gainAntipsychotic-induced weight gainEndocannabinoid metabolic enzymesPrior adult studiesTreatment-naive populationExcessive weight gainHigh-risk groupFatty acid amide hydrolaseTreatment of irritabilityChildren/adolescentsRisperidone studyAntipsychotic exposureAdverse eventsPlasma levelsRisk groupsAdult studiesCannabinoid receptorsNetwork trialAmide hydrolasePharmacogenetic basisGene variantsSignificant riskTrend associationNaive population